Welcome, Guest |
TOPIC:
Malaysia says "No" to Gilead Monopoly 6 years 7 months ago #25259
Today, which happens to be my birthday, Malaysia gave its citizens a present. Cabinet has agreed to issue a compulsory licence on the Gilead HCV medication Sofosbuvir. www.themalaymailonline.com/malaysia/arti...hepatitis-c-generics What this means is the Sofosbuvir patent can be ignored and Malaysia will be able to import generic Sofosbuvir. So what about Ledipasvir and Daclatasvir, afterall we need 2 drugs. No this won't impact that but it turns out DNDi, Pharco and Presidio have a rather tidy pan-genotypic NS5A inhibitor called Ravidasvir, which was co-incidentally trialled in Malaysia. This is essentially the same as Velpatasvir. So no prizes for joining the dots. Sofosbuvir+Ravidasvir - coming to a town near you (at least if you live in Malaysia). More on Ravidasvir here: www.dndi.org/diseases-projects/portfolio/sofosbuvir-hepc/ YMMV | |
Malaysia says "No" to Gilead Monopoly 6 years 7 months ago #25260
Happy Birthday, Doc!! This email address is being protected from spambots. You need JavaScript enabled to view it. Genotype 3 VL 4,100,000 ALT 101 AST 71 Treatment Naive Started Sof/Dac Jan 12, 2016 VL= <15 4 weeks in. AST/ALT normal. VL=UNDETECTED 8 weeks in. SVR4= Virus back. 3,300,000 Started generic Epclusa Sep. 23, 2017 4 weeks in <15 *Detected. 12 weeks in <15 *Not Detected. 16 weeks in <15 *Not Detected. Finished 24 weeks treatment 3-17-18 SVR5 <15 Not Detected. SVR 20 <15 Not Detected. SVR 44 <15 Not Detected. Thank you Jesus. Thank you Dr. James The following user(s) said Thank You: DrJames, Greedfighter | |
Time to create page: 0.063 seconds